Episode

HR-Positive Metastatic Breast Cancer — A Discussion and Debate on First- and Second-Line Therapy

Podcast
Breast Cancer Update
Published
Jun 11, 2026
Duration seconds
3502
Processing state
not_requested
Canonical source
https://breast-oncology.captivate.fm/episode/5904-cochrposmbc2025
Audio
https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/466caaa5-95c5-4277-b4e7-8354452eb045.mp3
JSON
/v1/public/podcasts/breast-cancer-update-757579/episodes/hr-positive-metastatic-breast-cancer-a-discussion-and-debate-on-first-and-second-line-therapy
Markdown
/podcast/breast-cancer-update-757579/hr-positive-metastatic-breast-cancer-a-discussion-and-debate-on-first-and-second-line-therapy.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/breast-cancer-update-757579/episodes/hr-positive-metastatic-breast-cancer-a-discussion-and-debate-on-first-and-second-line-therapy/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/breast-cancer-update-757579/hr-positive-metastatic-breast-cancer-a-discussion-and-debate-on-first-and-second-line-therapy.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Dr Sara A Hurvitz from the Fred Hutchinson Cancer Center in Seattle, Washington, and Dr Virginia Kaklamani from the UT Health San Antonio MD Anderson Cancer Center in San Antonio, Texas, discuss patient cases and review relevant data on the management of ER-positive, HER2-negative metastatic breast cancer. CME information and select publications